Pretzel Therapeutics is a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies. Pretzel was founded by leading academic experts in mitochondrial biology and is backed by a world-class investor syndicate.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/12/22 | $72,500,000 | Pre-A |
Angelini Ventures ARCH Venture Partners  Cambridge Enterprise Cambridge Innovation Capital Eir Ventures GU Ventures GV HealthCap Invus Karolinska Institutet Holding Mubadala Capital | undisclosed |
